Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 904 of 6351
-
Can a drug cocktail revive immunotherapy for breast cancer?
Disease control Recruiting nowThis is a Phase II, open-label, seven-arm parallel study evaluating the efficacy and safety of combined treatment (sodium cromoglicate, choline, efavirenz, SHR 1811, SHR 2102, mecapegfilgrastim, theophylline) with immune checkpoint inhibitor or immune checkpoint inhibitor rechall…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New asthma drug shows promise in reducing severe attacks
Disease control CompletedThis was a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment. The purpose of this study was to assess the efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants w…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a drug duo shrink Hard-to-Treat tumors?
Disease control Recruiting nowThe objective of this study is to assess the safety, efficacy, pharmacokinetics, and immunogenicity of MRG003 in combination with HX008 in patients with EGFR-positive advanced or metastatic solid tumors.
Phase 1/2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Algorithm could spot hidden dementia in routine doctor visits
Diagnosis CompletedThe eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.
Sponsor: Kaiser Permanente • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
ICD or not? landmark trial tests defibrillator necessity in seniors with heart failure.
Disease control Recruiting nowThe primary objective of DILEMMA study is to assess whether the "heart failure optimal therapy alone (HFOT)" strategy is non inferior to the "HFOT+ICD" strategy in terms of overall survival 48 months after randomization, in patients ≥ 70 years with an ICD indication for primary p…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo attack on rare cancer: immunotherapy joins chemo
Disease control PausedThis phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originat…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a cancer drug slow MS progression? new trial halted midway
Disease control PausedTo evaluate the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple sclerosis without relapse.
Phase 3 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New psoriasis drug could rival stelara in major trial
Disease control CompletedThis is a randomized, double-blind, active-controlled, parallel-group, multicenter study designed to compare the efficacy, safety, immunogenicity, and PK(Pharmacokinetic) of Bmab 1200 with Stelara in adult patients with moderate to severe chronic plaque psoriasis.
Phase 3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated Jun 26, 2026 16:50 UTC
-
New microscope could help brain surgeons see tumors in real time
Diagnosis Recruiting nowThe primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnormal tissue in vivo during brain tumor surgery. The interpretation of intraoperative images obtained in situ will be teste…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Can summer jobs and mentorship curb youth gun violence?
Prevention Recruiting nowThe goal of this study is to help build the evidence base for a locally-relevant youth firearm violence prevention program in Washington D.C., a city experiencing disparities in youth firearm violence outcomes. The main question it aims to answer is: How is youth participation …
Sponsor: University of Michigan • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
Immuno-chemo combo takes on hard-to-treat lymphoma
Disease control OngoingThis is an open-label, multicentre, randomised phase II trial in relapsed or refractory diffuse large B-cell lymphoma.
Phase 2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo aims to wipe out rare bladder cancer before surgery
Disease control Recruiting nowThis is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the pathologic complete response rate at cystectomy in patients after being treated…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Oxygen dilemma: which level saves preterm brains?
Disease control Recruiting nowPreterm birth, or birth before 37 weeks' gestation, is increasingly common, occurring in 8 percent of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks' gestation. At this gestational age, the lu…
Sponsor: University of Alberta • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a phone app help parents of kids with special needs thrive?
Symptom relief CompletedThis randomised controlled trial aims to determine the efficacy of a 12-week, smartphone-based Prosocial-orientated Acceptance and Commitment Training (PACT) programme plus age-appropriate positive parenting advice on the psychological flexibility, prosociality, parenting compete…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Could a routine blood clot test predict Cancer's next move?
Diagnosis Recruiting nowThe investigators hypothesize that abnormalities in thromboelastography (TEG) parameters in patients with liver, pancreas, biliary, esophageal, colorectal, and lung adenocarcinoma can serve as biomarkers for oncologic disease burden, cancer recurrence and overall survival as well…
Sponsor: University of Colorado, Denver • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
New hybrid heart procedure aims to tame stubborn AFib in heart failure patients
Disease control Recruiting nowA randomised controlled trial to assess the efficacy of staged hybrid ablation when compared with standard catheter ablation in patients with non-paroxysmal atrial fibrillation (AF) and Heart Failure
Sponsor: St. George's Hospital, London • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Contact lenses that could slow nearsightedness in kids
Disease control OngoingThe purpose of this post-approval study is to confirm the effectiveness of the MiSight 1 Day lens in clinical practices within the US and to assess the stability of the myopia reduction over one-year post-treatment.
Sponsor: CooperVision, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a better antidote stop opioid overdoses faster?
Disease control Stopped earlyn this pharmacokinetic/pharmacodynamic modelling study we will determine the ability of intranasal and intravenous naloxone and intravenous nalmefene to reverse opioid (fentanyl and sufentanil)- induced respiratory depression in healthy volunteers and chronic opioid users to deve…
Phase 1 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can needles quiet chronic pelvic pain?
Symptom relief CompletedBackground: Vulvodynia and chronic pelvic pain (CPP) are common and challenging gynecologic pain syndromes. A multidisciplinary approach is recommended. Study aim: To study the effectiveness of acupuncture as part of a multimodal treatment for women with vulvodynia and CPP. Des…
Sponsor: Medical University of Graz • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Bladder cancer breakthrough? drug combo aims to stop tumors returning
Disease control Recruiting nowThis is a phase II randomized controlled clinical trial comparing standard induction BCG versus bicalutamide and standard induction BCG among patients with non-muscle invasive bladder cancer.
Phase 2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC